BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18522765)

  • 1. Progesterone in traumatic brain injury: time to move on to phase III trials.
    Vandromme M; Melton SM; Kerby JD
    Crit Care; 2008; 12(3):153. PubMed ID: 18522765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another failed attempt of neuroprotection: progesterone for moderate and severe traumatic brain injury.
    Meyfroidt G; Taccone FS
    Minerva Anestesiol; 2016 Apr; 82(4):486-91. PubMed ID: 26126980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial.
    Xiao G; Wei J; Yan W; Wang W; Lu Z
    Crit Care; 2008; 12(2):R61. PubMed ID: 18447940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone for acute traumatic brain injury.
    Junpeng M; Huang S; Qin S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008409. PubMed ID: 21249708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone for acute traumatic brain injury.
    Ma J; Huang S; Qin S; You C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008409. PubMed ID: 23076947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
    Wright DW; Kellermann AL; Hertzberg VS; Clark PL; Frankel M; Goldstein FC; Salomone JP; Dent LL; Harris OA; Ander DS; Lowery DW; Patel MM; Denson DD; Gordon AB; Wald MM; Gupta S; Hoffman SW; Stein DG
    Ann Emerg Med; 2007 Apr; 49(4):391-402, 402.e1-2. PubMed ID: 17011666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.
    Howard RB; Sayeed I; Stein DG
    J Neurotrauma; 2017 Jun; 34(11):1915-1918. PubMed ID: 26370183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone for Traumatic Brain Injury: A Meta-Analysis Review of Randomized Controlled Trials.
    Lu XY; Sun H; Li QY; Lu PS
    World Neurosurg; 2016 Jun; 90():199-210. PubMed ID: 26960278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone neuroprotection: The background of clinical trial failure.
    Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
    J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma.
    Shakeri M; Boustani MR; Pak N; Panahi F; Salehpour F; Lotfinia I; Meshkini A; Daghighi S; vahedi P; Khani M; Taghiloo D
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2019-22. PubMed ID: 23871679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Progesterone for Acute Traumatic Brain Injury: a Meta-analysis of Randomized Controlled Trials.
    Wang Z; Shi L; Ding W; Shao F; Yu J; Zhang J
    Mol Neurobiol; 2016 Dec; 53(10):7070-7077. PubMed ID: 26676571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of progesterone treatment for ischaemic stroke.
    Gibson CL; Bath PM
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):487-91. PubMed ID: 26661235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent.
    Whitesides LW; Baren JM; Biros MH; Fleischman RJ; Govindarajan PR; Jones EB; Pancioli AM; Pentz RD; Scicluna VM; Wright DW; Dickert NW
    Clin Trials; 2017 Apr; 14(2):180-186. PubMed ID: 28359192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials.
    Stein DG
    Brain Inj; 2015; 29(11):1259-72. PubMed ID: 26274493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo-controlled trial of progesterone with or without hypothermia in patients with acute severe traumatic brain injury.
    Sinha S; Raheja A; Samson N; Goyal K; Bhoi S; Selvi A; Sharma P; Sharma BS
    Neurol India; 2017; 65(6):1304-1311. PubMed ID: 29133706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone for neuroprotection in pediatric traumatic brain injury.
    Robertson CL; Fidan E; Stanley RM; Noje C; Bayir H
    Pediatr Crit Care Med; 2015 Mar; 16(3):236-44. PubMed ID: 25581631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical trial of progesterone for severe traumatic brain injury.
    Skolnick BE; Maas AI; Narayan RK; van der Hoop RG; MacAllister T; Ward JD; Nelson NR; Stocchetti N;
    N Engl J Med; 2014 Dec; 371(26):2467-76. PubMed ID: 25493978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone in the clinical treatment of acute traumatic brain injury.
    Stein DG; Wright DW
    Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is progesterone a worthy candidate as a novel therapy for traumatic brain injury?
    Stein DG
    Dialogues Clin Neurosci; 2011; 13(3):352-9. PubMed ID: 22033509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury.
    Sayeed I; Stein DG
    Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.